These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33331887)

  • 21. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. deepDR: a network-based deep learning approach to in silico drug repositioning.
    Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
    Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deep mining heterogeneous networks of biomedical linked data to predict novel drug-target associations.
    Zong N; Kim H; Ngo V; Harismendy O
    Bioinformatics; 2017 Aug; 33(15):2337-2344. PubMed ID: 28430977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and application of a knowledge network for automatic prioritization of drug mechanisms.
    Mayers M; Tu R; Steinecke D; Li TS; Queralt-Rosinach N; Su AI
    Bioinformatics; 2022 May; 38(10):2880-2891. PubMed ID: 35561182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MultiDTI: drug-target interaction prediction based on multi-modal representation learning to bridge the gap between new chemical entities and known heterogeneous network.
    Zhou D; Xu Z; Li W; Xie X; Peng S
    Bioinformatics; 2021 Dec; 37(23):4485-4492. PubMed ID: 34180970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BiRWDDA: A Novel Drug Repositioning Method Based on Multisimilarity Fusion.
    Yan CK; Wang WX; Zhang G; Wang JL; Patel A
    J Comput Biol; 2019 Nov; 26(11):1230-1242. PubMed ID: 31140857
    [No Abstract]   [Full Text] [Related]  

  • 27. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
    Liu H; Song Y; Guan J; Luo L; Zhuang Z
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug repositioning based on the heterogeneous information fusion graph convolutional network.
    Cai L; Lu C; Xu J; Meng Y; Wang P; Fu X; Zeng X; Su Y
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34378011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting lncRNA-disease associations using network topological similarity based on deep mining heterogeneous networks.
    Zhang H; Liang Y; Peng C; Han S; Du W; Li Y
    Math Biosci; 2019 Sep; 315():108229. PubMed ID: 31323239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HKFGCN: A novel multiple kernel fusion framework on graph convolutional network to predict microbe-drug associations.
    Wu Z; Li S; Luo L; Ding P
    Comput Biol Chem; 2024 Jun; 110():108041. PubMed ID: 38471354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of drug-disease associations based on reinforcement symmetric metric learning and graph convolution network.
    Luo H; Zhu C; Wang J; Zhang G; Luo J; Yan C
    Front Pharmacol; 2024; 15():1337764. PubMed ID: 38384286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.
    Yang F; Zhang S; Pan W; Yao R; Zhang W; Zhang Y; Wang G; Zhang Q; Cheng Y; Dong J; Ruan C; Cui L; Wu H; Xue F
    Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug repositioning via Multi-view Representation Learning with Heterogeneous Graph Neural Network.
    Peng L; Yang C; Yang J; Tu Y; Yu Q; Li Z; Chen M; Liang W
    IEEE J Biomed Health Inform; 2024 Jul; PP():. PubMed ID: 39074005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MCHMDA:Predicting Microbe-Disease Associations Based on Similarities and Low-Rank Matrix Completion.
    Yan C; Duan G; Wu FX; Pan Y; Wang J
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):611-620. PubMed ID: 31295117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DDAPRED: a computational method for predicting drug repositioning using regularized logistic matrix factorization.
    Wang X; Yan R
    J Mol Model; 2020 Feb; 26(3):60. PubMed ID: 32062701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of drug-likeness using graph convolutional attention network.
    Sun J; Wen M; Wang H; Ruan Y; Yang Q; Kang X; Zhang H; Zhang Z; Lu H
    Bioinformatics; 2022 Nov; 38(23):5262-5269. PubMed ID: 36222555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RLFDDA: a meta-path based graph representation learning model for drug-disease association prediction.
    Zhang ML; Zhao BW; Su XR; He YZ; Yang Y; Hu L
    BMC Bioinformatics; 2022 Dec; 23(1):516. PubMed ID: 36456957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A graph regularized non-negative matrix factorization method for identifying microRNA-disease associations.
    Xiao Q; Luo J; Liang C; Cai J; Ding P
    Bioinformatics; 2018 Jan; 34(2):239-248. PubMed ID: 28968779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational drug repositioning with attention walking.
    Park JH; Cho YR
    Sci Rep; 2024 May; 14(1):10072. PubMed ID: 38698208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ITRPCA: a new model for computational drug repositioning based on improved tensor robust principal component analysis.
    Yang M; Yang B; Duan G; Wang J
    Front Genet; 2023; 14():1271311. PubMed ID: 37795241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.